Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Dupilumab effectively treated severe alopecia areata in a child.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

The gel effectively reduced folliculitis symptoms and was safe to use.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Teriflunomide can cause hair thinning.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Collagen CLR and placenta extract may help treat diffuse hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Deucravacitinib may effectively treat discoid lupus erythematosus.